New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 30, 2014
09:00 EDTCVS, MCKMcKesson extends pharmaceutical distribution agreement with CVS Caremark
McKesson Corporation (MCK) announced a three-year extension of its existing distribution agreement with CVS Caremark (CVS) through June, 2019. We have a long track record of delivering comprehensive supply chain solutions to CVS Caremark which in turn allows CVS Caremark to ensure the highest level of pharmaceutical care to its customers, said Paul Julian, executive vice president, group president, McKesson Corporation. We are pleased to have extended our agreement with CVS Caremark and continue our long standing partnership.
News For MCK;CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 1, 2015
09:12 EDTCVSOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Ocwen Financial (OCN), up 13.7%... Century Aluminum (CENX), Expedia (EXPE), up 6.1%... FireEye (FEYE), up 5.6%... Agnico Eagle Mines (AEM), up 3%... Gilead Sciences (GILD), up 2.9%... CVS Health (CVS), up 1.4%. ALSO HIGHER: EnerNOC (ENOC), up 26.5% after announcing collaboration with Tesla (TSLA)... Tesla up 1.2% after announcing Tesla Energy and partnerships... Cyberark (CYBR), up 2.9% after FireEye reported quarterly results... Cyberark (CY), up 2.5% after being upgraded to Strong Buy from Buy at Needham. DOWN AFTER EARNINGS: LinkedIn (LNKD), down 19.2%... Pixelworks (PXLW), down 7.5%... Cooper Tire (CTB), down 6.2%... JDS Uniphase (JDSU), down 3.2%... First Solar (FSLR), down 2.4%. ALSO LOWER: Tetralogic (TLOG), down 10.3% after 6.25M share Spot Secondary priced at $4.00.
08:53 EDTCVSCVS Health sees biosimilars to behave more like brands than traditional generics
CVS noted that the first biosimilar approval is just the beginning of approvals that could "unlock additional savings and provide options to clients." For the foreseeable future, CVS said it expects biosimilars to behave more like brands than traditional generics and the company expects to employ its formulary strategies to generate savings for its clients.
08:52 EDTCVSCVS Health sees FY15 free cash flow $5.9B-$6.2B
Subscribe for More Information
08:49 EDTCVSCVS Health sees Q2 adjusted EPS $1.17-$1.20, consensus $1.25
Subscribe for More Information
08:46 EDTCVSCVS Health sees FY15 revenue growth of 7%-8.25%
Subscribe for More Information
08:42 EDTCVSCVS Health says 2016 selling season 'off to a good start'
Updating on the 2015 selling season, CVS reported gross wins of $7.5B and net wins of $4.1B, both up about $500M from its last earnings update. The increases were driven primarily by growth in membership within some health plan clients as well as some additional wins. Regarding the 2016 season, CVS said it has completed about a third of client renewals, which is typical this time of year. CVS added that it remains "well-positioned to provide differentiated products and services that generate savings" for clients, which is "resonating strongly in the market." Comments from the company's earnings call and associated slides.
07:04 EDTCVSCVS Health opened 38 new retail drugstores and closed 10 retail drugstores
Subscribe for More Information
07:03 EDTCVSCVS Health reports Q1 Pharmacy Services revenue up 18.2% to $23.9B
Subscribe for More Information
07:02 EDTCVSCVS Health sees Q1 adjusted EPS $1.17-$1.20, consensus $1.25
Subscribe for More Information
07:02 EDTCVSCVS Health narrows FY15 adjusted EPS to $5.08-$5.19 from $5.05-$5.19
FY15 EPS consensus of $5.16. Backs FY15 free cash flow of $5.9B-$6.2B. Backs FY15 cash flow from operations $7.6B-$7.9B.
07:01 EDTCVSCVS Health reports Q1 adjusted EPS $1.14, consensus $1.08
Subscribe for More Information
April 30, 2015
15:01 EDTCVSNotable companies reporting before tomorrow's open
Subscribe for More Information
14:27 EDTMCK, CVSOmnicare attracts interest from CVS Health, Express Scripts, Bloomberg says
Omnicare (OCR) is attracting interest from Express Scripts (ESRX), and CVS (CVS), with other potential buyers including Walgreens Boots Alliance (WBA) and McKesson (MKC), Bloomberg reports, citing people with knowledge of the matter. Initial bids are due in May. Reference Link
14:16 EDTMCKOmnicare also drawing interest from Walgreens, McKesson, Bloomberg says
Subscribe for More Information
14:12 EDTCVSOmnicare said to attract interest from CVS Health Express Scripts
Subscribe for More Information
April 29, 2015
09:16 EDTCVSCVS announces new clinical affiliations with Louisiana, Mississippi organization
Subscribe for More Information
07:12 EDTCVSCVS Health volatility elevated into Q1 and outlook
Subscribe for More Information
April 23, 2015
13:16 EDTMCK, CVSPharmacies, PBMs seen as potential buyers after Omnicare said to explore sale
Subscribe for More Information
12:08 EDTCVSLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Larsen, along with Mary Ptacek, VP of Pharmaceutical Strategies Group and Ruth Krystopolski, EVP of Sanford Health, discuss the 2016-2017 Pharmacy Benefit Managers selling season and which PBMs are poised to gain share, the impact of WBAs growth plans, recent M&A activity and biosimilars on an Analyst/Industry conference call to be held on April 24 at 2 pm.
April 22, 2015
10:28 EDTCVSCVS Health April weekly call activity attributed to takeover chatter
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use